Discovery and validation of new biomarkers is one of the main objectives of contemporary medical research.  Thousands disease associated proteins have already been described. It is also acknowledged that no single molecule characterizes malignant state but protein profiles, also named biomarker panels.

Biomarker panels usually consist of 5 to 50 protein candidates and multiplexing tests are essential for their validation.  However, antibody-related assays still remain expensive and time consuming and most of them are generated to measure 1-5 proteins. Modern methods based on mass spectrometry are recognized to be more sensitive and efficient.

QconCAT technology corresponds to all the protein biomarker assay requirements  Multiplexing of up to 100 proteins Absolute quantification Highly sensitive Antibody-free Cost-efficient Highly reproducible Applicable to sample of any nature (blood, urine, CSF, tissue sample, etc)

 

QconCAT technology is an elegant solution for your biomarker discovery and validation projects. According to your needs you can choose from our biomarker related products and services.

 

QconCAT products

Ready kits

for protein biomarker quantification, composed of control isotope labeled protein mixtures for mass spectrometry analysis for different disease areas

- Cancer

- Cardiovascular diseases

- Neurodegenerative diseases

We invite area experts to suggest disease specific biomarker panels that could serve as inter laboratory controls and will allow creating available off-shelf kits for fast and reproducible protein quantification

Customized assays

We will create a quantification kit based on your proposed biomarker panel

QconCAT full service

If you are not equipped to perform mass spectrometry or if you want to save time and resources, we offer a full service where we create the QconCAT and perform the protein quantification of your samples in-house.

 

Contact our experts for more details and get professional advice on your protein quantification assay